Reasons Why Children and Adolescents With Attention-Deficit/Hyperactivity Disorder Stop and Restart Taking Medicine

被引:51
作者
Brinkman, William B. [1 ]
Simon, John O. [1 ]
Epstein, Jeffery N. [1 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, 3333 Burnet Ave,Mail Locat 7035, Cincinnati, OH 45229 USA
关键词
ADHD; adherence; adolescent; child; decision making; DEFICIT HYPERACTIVITY DISORDER; DECISION-MAKING; FOLLOW-UP; METHYLPHENIDATE; IMPAIRMENT; MEDICATION; ADHD; FRAMEWORK; INVOLVEMENT; PERFORMANCE;
D O I
10.1016/j.acap.2017.09.005
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
OBJECTIVE: To describe the prevalence of reasons why children and adolescents stop and restart attention-deficit/hyperactivity disorder (ADHD) medicine and whether functional impairment is present after stopping medicine. METHODS: We used the prospective longitudinal cohort from the Multimodal Treatment of Study of Children With ADHD. At the 12-year follow-up, when participants were a mean of 21.1 years old, 372 participants (76% male, 64% white) reported ever taking ADHD medicine. Participants reported the age when they last stopped and/or restarted ADHD medicine and also endorsed reasons for stopping and restarting. RESULTS: Seventy-seven percent (286 of 372) reported stopping medicine for a month or longer at some time during childhood or adolescence. Participants were a mean of 13.3 years old when they last stopped medicine. The most commonly endorsed reasons for stopping medication related to 1) medicine not needed/helping, 2) adverse effects, 3) logistical barriers of getting or taking medication, and 4) social concerns or stigma. Seventeen percent (64 of 372) reported restarting medicine after stopping for a month or longer. Commonly endorsed reasons for restarting related to medicine being needed or medicine helping; and resolution of logistical barriers to getting or taking medicine. For both stopping and restarting, the proportion endorsing some reasons differed by age range, with the overall pattern suggesting that parental involvement in decisions decreased with age. Nearly all participants had impairment at the assessment after stopping, regardless of whether medication was resumed. CONCLUSIONS: Different reasons for stopping and/or restarting medicine are relevant at different times for different teens. Tailored strategies may help engage adolescents as full partners in their treatment plan.
引用
收藏
页码:273 / 280
页数:8
相关论文
共 41 条
  • [1] Young adult outcome of hyperactive children: Adaptive functioning in major life activities
    Barkley, RA
    Fischer, M
    Smallish, L
    Fletcher, K
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2006, 45 (02) : 192 - 202
  • [2] BIRD HR, 1993, INT J METH PSYCH RES, V3, P167
  • [3] Relationship Between Attention-Deficit/Hyperactivity Disorder Care and Medication Continuity
    Brinkman, William B.
    Baum, Rebecca
    Kelleher, Kelly J.
    Peugh, James
    Gardner, William
    Lichtenstein, Phil
    Langberg, Joshua
    Epstein, Jeffery N.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2016, 55 (04) : 289 - 294
  • [4] In Their Own Words: Adolescent Views on ADHD and Their Evolving Role Managing Medication
    Brinkman, William B.
    Sherman, Susan N.
    Zmitrovich, April R.
    Visscher, Marty O.
    Crosby, Lori E.
    Phelan, Kieran J.
    Donovan, Edward F.
    [J]. ACADEMIC PEDIATRICS, 2012, 12 (01) : 53 - 61
  • [5] Parental Angst Making and Revisiting Decisions About Treatment of Attention-Deficit/Hyperactivity Disorder
    Brinkman, William B.
    Sherman, Susan N.
    Zmitrovich, April R.
    Visscher, Marty O.
    Crosby, Lori E.
    Phelan, Kieran J.
    Donovan, Edward F.
    [J]. PEDIATRICS, 2009, 124 (02) : 580 - 589
  • [6] Adolescent Outcomes of Childhood Attention-Deficit/Hyperactivity Disorder in a Diverse Community Sample
    Bussing, Regina
    Mason, Dana M.
    Bell, Lindsay
    Porter, Phillip
    Garvan, Cynthia
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2010, 49 (06) : 595 - 605
  • [7] Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents A Systematic Review
    Chan, Eugenia
    Fogler, Jason M.
    Hammerness, Paul G.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (18): : 1997 - 2008
  • [8] Exploring stimulant treatment in ADHD: narratives of young adolescents and their parents
    Charach, Alice
    Yeung, Emanuela
    Volpe, Tiziana
    Goodale, Tara
    dosReis, Susan
    [J]. BMC PSYCHIATRY, 2014, 14
  • [9] The impact of parents' medication beliefs on asthma management
    Conn, Kelly M.
    Halterman, Jill S.
    Lynch, Kathleen
    Cabana, Michael D.
    [J]. PEDIATRICS, 2007, 120 (03) : E521 - E526
  • [10] Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder
    Cox, Daniel J.
    Merkel, R. Lawrence
    Moore, Melissa
    Thorndike, Frances
    Muller, Carrie
    Kovatchev, Boris
    [J]. PEDIATRICS, 2006, 118 (03) : E704 - E710